Exploring deep
sea medicines
Posted AtThe
Financial Express
Although the oceans cover 70% of the
planet's surface, much of their biomedical potential
has gone largely unexplored, particularly in the Indian
Ocean. Until now.
December 05, 2005
Full
Story
Cadila to set up $2m centre
in Colombo
Posted Atmyiris.com
Cadila Pharmaceuticals is setting up
a bio-medical R&D centre in Colombo to produce life-saving
vaccines, reports Economic Times.
The project will focus on manufacturing vaccines for
life-threatening diseases like HIV, hepatitis B, hepatitis
C and other communicable diseases in Colombo, mainly
to provide them at affordable costs, according to sources.
December 05, 2005
Full
Story
Kalam for 'made in India' drugs
Posted Atmyiris.com
The country should have drugs designed,
developed, produced and marketed in India, President
A P J Abdul Kalam, said in Chennai after inagurating
Orchid Chemicals' new facility.
Stating that the research and drug design, development
and acceptance for introduction was indeed a challenging
mission, he said that molecule to drug was the business
of strong minds with the capacity to take calculated
risks.
December 05, 2005
Full
Story
Nektar India's R&D centre in
Hyderabad
Posted AtAndhracafe.com
The US-based drugs developing company
Nektar Therapeutics (India), has started its research
and development centre in Hyderabad. This is the company's
second overseas centre next to its UK branch.
The R&D centre located in the ICICI Knowledge Park will
support the pre-clinical and bio-analytical development
of proprietary and partner products. The company would
like to fully integrate its Indian operations into Research
and developmental work.
December 05, 2005
Full
Story
|
